These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 14729392)

  • 1. Nuclear inositides: facts and perspectives.
    Martelli AM; Manzoli L; Cocco L
    Pharmacol Ther; 2004 Jan; 101(1):47-64. PubMed ID: 14729392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New frontiers of inositide-specific phospholipase C in nuclear signalling.
    Cocco L; Maraldi NM; Manzoli FA
    Eur J Histochem; 2004; 48(1):83-8. PubMed ID: 15145779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphoinositide-specific phospholipase C (PI-PLC) beta1 and nuclear lipid-dependent signaling.
    Cocco L; Faenza I; Fiume R; Maria Billi A; Gilmour RS; Manzoli FA
    Biochim Biophys Acta; 2006; 1761(5-6):509-21. PubMed ID: 16624616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear phosphoinositides and their roles in cell biology and disease.
    Martelli AM; Ognibene A; Buontempo F; Fini M; Bressanin D; Goto K; McCubrey JA; Cocco L; Evangelisti C
    Crit Rev Biochem Mol Biol; 2011 Oct; 46(5):436-57. PubMed ID: 21913876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-examination of the mechanisms regulating nuclear inositol lipid metabolism.
    Martelli AM; Bortul R; Tabellini G; Aluigi M; Peruzzi D; Bareggi R; Narducci P; Cocco L
    FEBS Lett; 2001 Sep; 505(1):1-6. PubMed ID: 11557031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear lipid-dependent signal transduction in human osteosarcoma cells.
    Maraldi NM; Marmiroli S; Cocco L; Capitani S; Barnabei O; Manzoli FA
    Adv Enzyme Regul; 1997; 37():351-75. PubMed ID: 9381981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear PI-PLCβ1: an appraisal on targets and pathology.
    Follo MY; Faenza I; Piazzi M; Blalock WL; Manzoli L; McCubrey JA; Cocco L
    Adv Biol Regul; 2014 Jan; 54():2-11. PubMed ID: 24296032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation.
    Faenza I; Billi AM; Follo MY; Fiume R; Martelli AM; Cocco L; Manzoli L
    Anticancer Res; 2005; 25(3B):2039-41. PubMed ID: 16158942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear inositol lipid metabolism: more than just second messenger generation?
    Martelli AM; Follo MY; Evangelisti C; Falà F; Fiume R; Billi AM; Cocco L
    J Cell Biochem; 2005 Oct; 96(2):285-92. PubMed ID: 16088939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear inositide specific phospholipase C signalling - interactions and activity.
    Faenza I; Fiume R; Piazzi M; Colantoni A; Cocco L
    FEBS J; 2013 Dec; 280(24):6311-21. PubMed ID: 23890371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol lipid cycle and autonomous nuclear signalling.
    Cocco L; Capitani S; Maraldi NM; Mazzotti G; Barnabei O; Gilmour RS; Manzoli FA
    Adv Enzyme Regul; 1996; 36():101-14. PubMed ID: 8869743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear phosphoinositides: location, regulation and function.
    Fiume R; Keune WJ; Faenza I; Bultsma Y; Ramazzotti G; Jones DR; Martelli AM; Somner L; Follo MY; Divecha N; Cocco L
    Subcell Biochem; 2012; 59():335-61. PubMed ID: 22374096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of phosphoinositides, regulators of multiple cellular functions.
    Balla T
    Curr Pharm Des; 2001 Apr; 7(6):475-507. PubMed ID: 11281854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inositides in the nucleus: further developments on phospholipase C beta 1 signalling during erythroid differentiation and IGF-I induced mitogenesis.
    Cocco L; Capitani S; Barnabei O; Gilmour RS; Rhee SG; Manzoli FA
    Adv Enzyme Regul; 1999; 39():287-97. PubMed ID: 10470379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear inositol lipid signaling and its potential involvement in malignant transformation.
    Martelli AM; Manzoli L; Faenza I; Bortul R; Billi A; Cocco L
    Biochim Biophys Acta; 2002 Oct; 1603(1):11-7. PubMed ID: 12242107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear phosphoinositides and their functions.
    Hammond G; Thomas CL; Schiavo G
    Curr Top Microbiol Immunol; 2004; 282():177-206. PubMed ID: 14594218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of phospholipase C beta, gamma, and delta families alters cell growth and phosphatidylinositol 4,5-bisphosphate levels.
    Nebigil CG
    Biochemistry; 1997 Dec; 36(50):15949-58. PubMed ID: 9398329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear phospholipase C: a novel aspect of phosphoinositide signalling.
    Manzoli L; Billi AM; Faenza I; Matteucci A; Martelli AM; Peruzzi D; Falconi M; Rhee SG; Gilmour RS; Cocco L
    Anticancer Res; 1999; 19(5A):3753-6. PubMed ID: 10625953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inositides and the nucleus: phospholipase Cbeta family localization and signaling activity.
    Cocco L; Martelli AM; Mazzotti G; Barnabei O; Manzoli FA
    Adv Enzyme Regul; 2000; 40():83-95. PubMed ID: 10828347
    [No Abstract]   [Full Text] [Related]  

  • 20. Inositides in the nucleus: regulation of nuclear PI-PLCbeta1.
    Cocco L; Martelli AM; Vitale M; Falconi M; Barnabei O; Stewart Gilmour R; Manzoli FA
    Adv Enzyme Regul; 2002; 42():181-93. PubMed ID: 12123715
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.